Sway System (Sports Plus)
Sway Medical, Inc. · Decision date Oct 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Sway System (Sports Plus), submitted by Sway Medical, Inc. of Tulsa, Oklahoma, under 510(k) number K262000. The record lists the device classification as Computerized Cognitive Assessment Aid For Concussion, regulation number 882.1471, with primary product code POM and subsequent product code LXV. The application was received on 06/15/2026 and decided on 10/18/2026; the review panel and regulation medical specialty are both Neurology.
SESE denotes 510(k) clearance rather than PMA approval, and the record describes a Traditional submission that was not reviewed by a third party, was not a combination product, and had no authorized Predetermined Change Control Plan. The page does not identify specific components, software changes or performance data supporting the decision, and no clearance statement text is included in the available record.
The public record does not state indications for use, patient-selection criteria or clinical performance results, so those details remain unknown here and would need to be read from the underlying FDA documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Oct 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262000
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Sway Medical, Inc.
- Product code
- POM
- Decision code
- SESE
- Decision date
- Oct 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Computerized Cognitive Assessment Aid For Concussion.
- Applicant
- Sway Medical, Inc.
- Product code
- POM
- FDA device class
- 2
FDA decision timeline
K262000 received
Application receipt date recorded by FDA.
K262000 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sway Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tulsa, OK
Sources and methodology
- Original FDA record: K262000
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records